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Summary The purpose of this study was to examine the relation between
depression, anxiety and pulmonary function in asthmatics. Thirty-eight adult
asthmatic patients underwent psychometric evaluation with the DSSI/sAD ques-
tionnaire, filled in an asthma questionnaire and underwent spirometry. The majority
of patients suffered from mild-persistent asthma. Twenty-six reported symptoms of
anxiety and 25 reported symptoms of depression. A statistically significant reduction
in FEV1 and FEV1/FVC values was observed in asthmatic patients with symptoms of
depression. The mean value of FEV1 was 81.84(720.83) in patients without
symptoms and 63.73(717.99) in patients with symptoms of depression. The mean
values of FEV1/FVC were 0.85(70.11) and 0.75(70.10), respectively. These findings
indicate a high frequency of depression and anxiety in adult asthmatic patients. A
biological linkage between depression and impaired pulmonary function is proposed.
& 2003 Elsevier Ltd. All rights reserved.
Introduction
Anxiety and depression are closely related to
asthma.1 Estimates of psychopathology in severe
asthmatics range from 30% to 63%.2,3 Children with
asthma have higher rates of depression than
children with certain other chronic medical condi-
tions.4 Exposure to stress and strong emotions can
make asthma worse, while having asthma can give
patient an increased vulnerability towards the
development of anxiety disorders.5,6 Whether
these high rates of depression and anxiety observed
in asthmatics are due to the consequence of the
disease only or there is also a genetic link between
asthma and psychiatric disorders is controversial.3
On the other hand, psychiatric symptoms in
asthmatic patients have been shown to be a
risk factor for increased asthma morbidity and
mortality.7
The present study investigated the relation be-
tween asthma and anxiety, asthma and depression
and particularly the possible impact of these psy-
chiatric disorders on the pulmonary function tests.
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Samples and methods
Subjects
We selected 40 asthmatic patients (14 women; age
range: 17–65 year old.). Patients were consecu-
tively recruited during a 3-month period among
patients that visited the University outpatient
pulmonology clinic and asthma diagnosis was made
according to Global Initiative for Asthma (GINA)
guidelines. Asthma was diagnosed by the Lung
Function Laboratory of the Physiology Department
of the University of Thessaly. Most patients had
already a clinical asthma diagnosis made by a G.P.
or a Pulmologist and they visited University
Laboratory for the confirmation of the diagnosis
and further investigation. Others attented the
University outpatient pulmonology clinic. The
diagnosis of asthma was based on clinical findings,
spirometry, and provocation tests, as necessary
(reversibility in FEV1 and/or airway hyperrespon-
siveness to histamine). We only included lifetime
non-smoking patients, with no previous history of
near fatal asthma attack or hospitalization for
asthma. Subjects did not experience respiratory
infections or spontaneous asthmatic relapses during
the 4 weeks preceding study. Two patients refused
to undergo the psychological evaluation. The finally
38 enrolled patients were receiving anti-asthmatic
therapy on a regular basis or as needed. All these
patients were on inhaled medication only. Degree
of asthma severity was assessed according GINA
guidelines.8 A brief asthma questionnaire based
upon a scale proposed by Woolcock and Jenkins9
was used. Assessment of asthma severity was based
on symptoms and use of anti-asthmatic drugs. For
length of asthmatic history, we divided asthmatics
into three groups: subjects with newly diagnosed
asthma (duration of the disease p1 year), subjects
with long asthmatic history and with prolonged
history of asthma (duration of the disease 41 and
p10 and 410 years; respectively).
Before entering the study, each patient attended
a screening interview by a psychiatrist (N.A) to rule
out any form of present or past mental disorder
according to the Greek version of ICD- 10.10 No
subjects reported history of cognitive impairment,
low instructional level, recent negative life events,
and past or present endocrine or metabolic
disorder, obesity or recent weight loss, drug or
alcohol addiction. Presence of atopy was not a
prerequisite for selection. Atopy was assessed by
skin prick tests to a standard battery of eight
common inhalant allergens.
Pulmonary function assessment
Pulmonary function was measured by a flow-sensing
spirometer connected to a computer for data
analysis. Forced expiratory volume in the 1st
second (FEV1), forced vital capacity (FVC) and the
ratio FEV1/FVC were calculated. FEV1/FVC is an
index of airway obstruction.
Psychometric evaluation
Each patient underwent psychometric evaluation
with the Bedford and Fould’s (DSSI/sAD) inven-
tory.11,12 It consists of 14 questions, seven measur-
ing anxiety and seven depression. The sAD scale is
statistically a highly acceptable measure of general
psychological disturbance.13 It is an indicator of the
intensity of anxiety and depression. The total score
for each subscale is the sum of its item scores (0–
21). The cut-off score for each subscale is 3. A score
below 3 (p3) means no psychiatric symptomatol-
ogy, a score between 3 and 6 indicates some sort of
borderline symptomatology, while people that
score above 6 should be regarded as psychiatric
patients. Approximately 95% of healthy individuals
give scores below the cut-off score, and should be
regarded as free from psychiatric symptoms; 2.2%
give score between 3 and 6 and they are regarded
as having some sort of borderline symptomatology,
while 1.4% score above six ð46Þ and could be
regarded as having significant psychopathology.
Thus a cumulative 5.1% of healthy persons score
above the 4þ threshold. On the contrary, percen-
tages exceeding the 4þ threshold on state of
anxiety and depression among psychiatric patients
are 71.3% and 69%, respectively.11 High compliance
has been reported in both non-psychiatric patient
and non-patient groups. British adult norms are
used as a reference in this study, as the existing
studies of validity and psychometric structures of
sAD are based upon British patients.11,13 However,
results from other countries, including Greece,
highlighted the need for local norms in transcultur-
al research.13
Variables and data analysis
FEV1 values were expressed as percent of predicted
values. In order to include persons with even minor
manifestations of depression and anxiety, separate
categorical variables for anxiety and depression
that included the patients scoring below the cut-off
score (p3) and above 3 were defined. Independent
samples T-test was used to assess differences in
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pulmonary parameters between these groups.
Comparisons of proportions were evaluated by
means of w2:14 A P value less than 0.05 was
considered significant. Statistics was processed by
SPSS for Windows, 7.5 version (Standard Version,
1996, SPSS Inc., Chicago, IL, USA).
Results
The subjects’ characteristics are shown in Table 1.
The mean age of the patients was 47 year. Female
were 14 individuals. Twenty-five out of 38 patients
were atopic. The mean duration of asthmatic
disease was 6.5 years with a range of 0.5–40 years.
The mean values of FEV1 and FEV1/FVC were 71.8
and 0.81, respectively. According to asthma symp-
toms and also taking into account the use of drugs,
28 out of 38 patients were presented with either
intermittent or mild-persistent asthma (less than
500 mg of BDP or equivalent). Seven patients were
classified as having moderate-persistent asthma
and two as severe-persistent (8). Twenty-six pa-
tients (68.5%) reported symptoms of anxiety and
25(65.8%) patients reported symptoms of depres-
sion (score43 in DSSI/sAD inventory) (Tables 2 and
3). Mean value for anxiety scale was 7.9(SD:5.1)
and for depression 5.6(SD:4.5). Twelve (31.5%) and
18(47.3%) patients could be regarded as having
significant psychopathology since their score was
above 6 in the scales of depression and anxiety,
respectively, compared with the 1.4% reported in
healthy individuals. Asthmatic patients had a
statistically significant higher score in psychometric
evaluation in comparison with normals (Table 2).
Symptoms of depression were found to be
associated with a statistically significant reduction
in the values of FEV1 and FEV1/FVC, when patients
with no symptoms (score p3) were compared with
patients with some kind of depressive symptoms
(either mild or severe psychopathology-score 43).
The mean value of FEV1 was 81.84(720:83)
in patients without symptoms and 63.73(717:99)
in patients with symptoms of depression. The mean
values of FEV1/FVC were 0.85(70:11) and
0.75(70.10), respectively. On the contrary, pa-
tients with symptoms of anxiety had no statistical
differences in the pulmonary measures compared
with patients without any symptoms (mean value of
FEV1 was 84:7570:91 in patients without symptoms
and 71:6379:94 in patients with symptoms of
anxiety, P:NS).
Discussion
Psychological disturbances are positively related to
the severity of asthma.1 The same happens in other
chronic conditions. Frequent admissions to hospi-
tal, inability to work and limitations in other
activities often lead to behavioral problems in-
dicative of psychiatric morbidity.15 Although there
is not a unique pattern attributable solely to
asthma, sometimes the scores in psychometric
evaluation are proven to be higher than in other
severe chronic conditions, such as diabetes melli-
tus.4 Rates of anxiety and depression in this study
were compatible with prior clinical studies, report-
ing increased rates of anxiety and depressive
disorders in persons with asthma. Yellowlees
et al.,2 studied adult patients with asthma and
found psychiatric morbidity in 58% of the sample
with anxiety disorders being the most common
diagnosis. High levels of anxiety and marked
emotional imbalance characterize asthmatic pa-
tients.16 Certain personality profiles are detected
in adult asthmatics.8 Affective and anxiety dis-
orders are more common in children with asthma.17
Lower rates, however, have been demonstrated in
epidemiological samples. These differences could
be attributed to selection bias in clinical studies,
where sicker patients are more likely to volunteer
to participate in research.18 Greek populations
exhibit higher scores in sAD scales by contrast with
the initial British norms.13 Lyketsos et al.,19 trans-
lated the sAD into Greek and collected data on 220
healthy women with means of anxiety of 3.2 and
depression of 2.2, significantly higher than Greek
men. However, the scores in the present study still
remain considerably high. Indeed, percentages
above the threshold were quite close to those
obtained from British psychiatric patients and
comparable to data from psychosomatic groups in
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Table 1 Subjects’ characteristics (n¼ 38).
Patients with
intermmitent/mild-
persistent asthma (n)
28
Sex, F/M 14/24
Ltopy yes/no 25/13
Age (yr)
Mean 47
Range (17–65)
Duration of disease (yr)
Mean 6.5
Range (0.5–40)
FEV1 (% pred)
Mean 71.8
Range (44–119)
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Greece, including patients with hypertension,
irritable bowel syndrome, psoriasis and inpatients
with bronchial asthma.13 In the latter, the inpati-
ents’ sAD mean of 13.4 on admission grossly
exceeded control and norms scores.20
Depression and anxiety have been shown to be
risk factors for increased asthma morbidity and
mortality. Moderate to severe asthma, pessimistic
attitude towards prognosis, high levels of denial
and non-compliance lead to steroid dependency
and deaths from asthma.1,7 Most studies refer to
severe asthma.2–6 In this study, patients were
presented with mild asthma. Nevertheless, they
scored significantly high in the scales of anxiety and
depression reminding of more severely ill somatic
patients. If few crises during the year cause far less
embarrassment compared to severe and difficult-
to-control asthma, the scores observed in the
psychiatric tests could hardly be attributed to the
chronic disease alone. Moreover, there is some
evidence that even mild asthma is associated with
anxiety and depression.18 This may be consistent
with common underlying mechanisms. Defects in
the function of the autonomic nervous system such
as a-adrenergic and cholinergic hyperresponsive-
ness and b-adrenergic hyporesponsiveness even
distal from the airways has been demonstrated in
asthmatic patients, as well as in depression. More-
over, in depression, studies of central mediators in
the brain also demonstrate parasympathetic hyper-
responsiveness and b-adrenergic responsiveness.21
Although a similar imbalance to the autonomic
nervous in the central nervous system is yet to be
found in asthmatics, these data raise the question
of common biological pathways. It is supported that
depression and asthma may each have similar
relative transmitter imbalance that additevely
worsen the severity of either or both in a given
patient.22 Wamboldt et al.,3 suggested a possible
genetic risk for both depression and asthma.
However, this also may represent the contribution
of medication and resultant side effects.23 In this
study, patients were on inhaled medication and no
constitutional effects were expected. The environ-
mental link between psychopathology and asthma
seems to be less strong in these cases in favor of a
biological-genetic one, which could make asth-
matics more liable to psychiatric disorders.
In this study, a statistically significant difference
was observed in FEV1 and FEV1/FVC values between
asthmatic individuals with symptoms of depression
and asthmatics with no depressive symptoms. No
such difference was observed in persons with
symptoms of anxiety. This could be attributed to
a common biological pathway between asthma and
depression, but not anxiety, or simply to the small
size of the samples. Emotional disturbances have
been associated with low scores in objective
pulmonary measures. Asthmatic attacks and reduc-
tion in FEV1 have been intentionally induced in
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Table 2 Distribution of anxiety and depression scores in asthmatic patientsFDSSI/sAD (n¼ 38).
Scale of anxiety Scale of depression Expectedn
(n¼ 38) mean: 7.9, SD (5.1) (n¼ 38) mean: 5.6, SD (4.5) mean: (sA:0.9,SD:0.6.), SD: (sA: 1.3, SD 1.5)
n % n % n %
p3 12 31.5 13 34.2 31 94.9
43 26 68.5 25 65.8 2 5.1
Total 38 100 38 100 38 100
In healthy individuals.
nPo0.05.
Table 3 Differences in pulmonary measures between asthmatic patients with symptoms of depression (score43
in DSSI/sAD) and patients with no symptoms of depression (scorep3 in DSSI/sAD).
Patients with no symptoms (n¼ 13) Patients with symptoms of depression (n¼ 25) Pn
Mean 7 SD Mean 7 SD
FEV1 81.84 7 20.83 63.73 7 17.99 o0.05
FVC 96.30 7 25.02 84.72 7 23.40 NS
FEV1/FVC 0.85 7 0.11 0.75 7 0.10 o0.05
nT-test.
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asthmatic patients through exposure to emotional
stimuli.24 Gustaffson et al.,25 found a negative
correlation between peak expiratory flow (PEF) in
children and disturbed family cohesion in non-
steroid dependent cases. In another study of ours,
asthmatic attacks were more frequent in children
with mild asthma, whose parents had high scores of
anxiety and depression in sAD scales. This finding
was attributed rather to a biological link than the
disease of the children.26 There is also some
suggestion in the literature that treating the
anxiety or depression of the asthmatic may actually
improve the control of asthma.6,27 Subjects given
biofeedback training for facial relaxation exhibited
higher pulmonary scores and more positive atti-
tudes towards asthma.28
This study focuses on the issue that the presence
of depressive symptoms in adult asthmatics may
indicate worse objective pulmonary measures. If
so, this could also mean that a most aggressive
therapy and psychological support are necessary in
these patients. The findings of this study lend
support to the hypothesis that there are further
implications between depression and asthma and
that common biological pathways may exist. How-
ever, this was a preliminary study. Further studies
confirming our findings are necessary. These could
probably include the use of psychiatric drugs and
their possible impact on the course of asthma. The
results of this study emphasized the relations
between psychiatric parameters and pulmonary
measures and support the provision of intervention
services to asthmatics.
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